[HTML][HTML] RND multidrug efflux pumps: what are they good for?

C Alvarez-Ortega, J Olivares, JL Martínez - Frontiers in microbiology, 2013 - frontiersin.org
Multidrug efflux pumps are chromosomally encoded genetic elements capable of mediating
resistance to toxic compounds in several life forms. In bacteria, these elements are involved …

Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumps

C Plé, HK Tam, A Vieira Da Cruz, N Compagne… - Nature …, 2022 - nature.com
Efflux transporters of the RND family confer resistance to multiple antibiotics in Gram-
negative bacteria. Here, we identify and chemically optimize pyridylpiperazine-based …

A mass spectrometry-based assay for improved quantitative measurements of efflux pump inhibition

AR Brown, KA Ettefagh, D Todd, PS Cole, JM Egan… - PLoS …, 2015 - journals.plos.org
Bacterial efflux pumps are active transport proteins responsible for resistance to selected
biocides and antibiotics. It has been shown that production of efflux pumps is up-regulated in …

Radixin knockdown improves the accumulation and efficiency of methotrexate in tumor cells

A Kawase, Y Inoue, S Nakazaki… - Oncology …, 2019 - spandidos-publications.com
The plasma membrane localization of efflux transporters, such as multidrug resistance‑
associated protein (MRP/ABCC), is governed by scaffold proteins, such as the …

Berberine Derivatives as Pseudomonas aeruginosa MexXY-OprM Inhibitors: Activity and In Silico Insights

G Giorgini, G Mangiaterra, N Cedraro, E Laudadio… - Molecules, 2021 - mdpi.com
The natural alkaloid berberine has been demonstrated to inhibit the Pseudomonas
aeruginosa multidrug efflux system MexXY-OprM, which is responsible for tobramycin …

Efflux as a mechanism of antimicrobial drug resistance in clinical relevant microorganisms: the role of efflux inhibitors

C Willers, JF Wentzel, LH Du Plessis… - Expert opinion on …, 2017 - Taylor & Francis
Introduction: Microbial resistance against antibiotics is a serious threat to the effective
treatment of infectious diseases. Several mechanisms exist through which microorganisms …

The 2019 Garrod lecture: MDR efflux in gram-negative bacteria—How understanding resistance led to a new tool for drug discovery

LJV Piddock - Journal of Antimicrobial Chemotherapy, 2019 - academic.oup.com
Abstract The AcrAB-TolC MDR efflux system confers intrinsic MDR and overproduction
confers clinically relevant resistance to some antibiotics active against Gram-negative …

Microbe-Derived Indole Metabolite Demonstrates Potent Multidrug Efflux Pump Inhibition in Staphylococcus aureus

R Tambat, M Jangra, N Mahey, N Chandal… - Frontiers in …, 2019 - frontiersin.org
Efflux pumps are always at the forefront of bacterial multidrug resistance and account for the
failure of antibiotics. The present study explored the potential of 2-(2-Aminophenyl) indole …

Microbial efflux pump inhibition: tactics and strategies

GP Tegos, M Haynes, J Jacob Strouse… - Current …, 2011 - ingentaconnect.com
Traditional antimicrobials are increasingly suffering from the emergence of multidrug
resistance among pathogenic microorganisms. To overcome these deficiencies, a range of …

Synthesis and evaluation of inhibitors of bacterial drug efflux pumps of the major facilitator superfamily

BO Okandeji, DM Greenwald, J Wroten… - Bioorganic & medicinal …, 2011 - Elsevier
Inhibitors of drug efflux pumps have great potential as pharmacological agents that restore
the drug susceptibility of multidrug resistant bacterial pathogens. Most attention has been …